ALS (motor neurone disease) trials in Israel
6 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peoplePridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- Where
- Jerusalem, Tel Aviv
- Age
- 18 years to 80 years
- People
- 500 worldwide
- Run by
- Prilenia
See details and how to joinNCT07322003 - No phaseTaking peopleALS/MND Natural History Study Data Repository
- Where
- Jerusalem, Tel Aviv
- Age
- 18 years to 90 years
- People
- 5,000 worldwide
- Run by
- Massachusetts General Hospital
See details and how to joinNCT05966038 - Phase 3Taking peopleEfficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Where
- Jerusalem, Tel Aviv
- Age
- 18 years to 81 years
- People
- 495 worldwide
- Run by
- AB Science
See details and how to joinNCT03127267 - No phaseTaking peopleDerivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells
- Where
- Jerusalem
- Age
- 18 years and over
- People
- 25
- Run by
- Hadassah Medical Organization
See details and how to joinNCT00801333 - No phaseTaking peopleDevelopment of IPS from Donated Somatic Cells of Patients with Neurological Diseases
- Where
- Jerusalem
- Age
- 18 years and over
- People
- 120
- Run by
- Hadassah Medical Organization
See details and how to joinNCT00874783 - No phaseTaking peopleInvestigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)
- Where
- Jerusalem
- Age
- 12 years to 120 years
- People
- 2,000
- Run by
- Hadassah Medical Organization
See details and how to joinNCT03366506